TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation

W. G. Van Eyndhoven, Christopher Gamper, E. Cho, W. J M Mackus, S. Lederman

Research output: Contribution to journalArticle

Abstract

Although TRAF-3 gene products are required for signaling in T-B cell collaboration, full-length TRAF-3 appears to lack signaling function in transient transfection assays that measure NF-κB activation. However, the TRAF-3 gene also encodes at least three mRNA splice-deletion variants that predict protein isoforms (Δ25aa, Δ52aa and Δ56aa) with altered zinc (Zn) finger domains and unknown functional capacities. To determine whether TRAF-3 splice-deletion variants may transmit activating receptor signals to the nucleus, cDNAs for five additional splice-variant isoforms (Δ27aa, Δ83aa, Δ103aa, Δ130aa and Δ221aa) were cloned from a TRAF-3+ lymphoma and the expression and function of each of the eight TRAF-3 splice-deletion variants was analyzed. Among the splice-deletion variants, TRAF-3 Δ130 mRNA is expressed by tonsillar B cells and by each of a panel of B and T cell lines. TRAF-3 Δ221 protein is expressed by tonsillar B cells and by each of the lymphocytic lines. The functional effect of over-expressing each TRAF-3 splice-deletion variant on NF-κB activation was studied in 293 T cells. Seven of the TRAF-3 splice-deletion variants, such as TRAF-3 Δ130, induce substantial NF-κB-driven luciferase activity (80-500 fold). In contrast, TRAF-3 Δ221 (in which the complete Zn finger domain is absent) fails to induce NF-κB activation. Although full-length TRAF-3 alone is inactive, it augments the functional effects of the seven activating TRAF-3 splice- deletion variants (1.45 fold). These data indicate that alterations of the Zn finger domains render the TRAF-3 splice-deletion variants capable of inducing NF-κB activation and that full-length TRAF-3 augments their signaling.

Original languageEnglish (US)
Pages (from-to)647-658
Number of pages12
JournalMolecular Immunology
Volume36
Issue number10
DOIs
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

TNF Receptor-Associated Factor 3
Protein Isoforms
Messenger RNA
Zinc Fingers
B-Lymphocytes
T-Lymphocytes

Keywords

  • Molecular biology
  • Signal transduction
  • T cell-B cell collaboration

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation. / Van Eyndhoven, W. G.; Gamper, Christopher; Cho, E.; Mackus, W. J M; Lederman, S.

In: Molecular Immunology, Vol. 36, No. 10, 07.1999, p. 647-658.

Research output: Contribution to journalArticle

Van Eyndhoven, W. G. ; Gamper, Christopher ; Cho, E. ; Mackus, W. J M ; Lederman, S. / TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation. In: Molecular Immunology. 1999 ; Vol. 36, No. 10. pp. 647-658.
@article{7c8a7416463d4454a18a4bbc46c66bd8,
title = "TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation",
abstract = "Although TRAF-3 gene products are required for signaling in T-B cell collaboration, full-length TRAF-3 appears to lack signaling function in transient transfection assays that measure NF-κB activation. However, the TRAF-3 gene also encodes at least three mRNA splice-deletion variants that predict protein isoforms (Δ25aa, Δ52aa and Δ56aa) with altered zinc (Zn) finger domains and unknown functional capacities. To determine whether TRAF-3 splice-deletion variants may transmit activating receptor signals to the nucleus, cDNAs for five additional splice-variant isoforms (Δ27aa, Δ83aa, Δ103aa, Δ130aa and Δ221aa) were cloned from a TRAF-3+ lymphoma and the expression and function of each of the eight TRAF-3 splice-deletion variants was analyzed. Among the splice-deletion variants, TRAF-3 Δ130 mRNA is expressed by tonsillar B cells and by each of a panel of B and T cell lines. TRAF-3 Δ221 protein is expressed by tonsillar B cells and by each of the lymphocytic lines. The functional effect of over-expressing each TRAF-3 splice-deletion variant on NF-κB activation was studied in 293 T cells. Seven of the TRAF-3 splice-deletion variants, such as TRAF-3 Δ130, induce substantial NF-κB-driven luciferase activity (80-500 fold). In contrast, TRAF-3 Δ221 (in which the complete Zn finger domain is absent) fails to induce NF-κB activation. Although full-length TRAF-3 alone is inactive, it augments the functional effects of the seven activating TRAF-3 splice- deletion variants (1.45 fold). These data indicate that alterations of the Zn finger domains render the TRAF-3 splice-deletion variants capable of inducing NF-κB activation and that full-length TRAF-3 augments their signaling.",
keywords = "Molecular biology, Signal transduction, T cell-B cell collaboration",
author = "{Van Eyndhoven}, {W. G.} and Christopher Gamper and E. Cho and Mackus, {W. J M} and S. Lederman",
year = "1999",
month = "7",
doi = "10.1016/S0161-5890(99)00079-6",
language = "English (US)",
volume = "36",
pages = "647--658",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation

AU - Van Eyndhoven, W. G.

AU - Gamper, Christopher

AU - Cho, E.

AU - Mackus, W. J M

AU - Lederman, S.

PY - 1999/7

Y1 - 1999/7

N2 - Although TRAF-3 gene products are required for signaling in T-B cell collaboration, full-length TRAF-3 appears to lack signaling function in transient transfection assays that measure NF-κB activation. However, the TRAF-3 gene also encodes at least three mRNA splice-deletion variants that predict protein isoforms (Δ25aa, Δ52aa and Δ56aa) with altered zinc (Zn) finger domains and unknown functional capacities. To determine whether TRAF-3 splice-deletion variants may transmit activating receptor signals to the nucleus, cDNAs for five additional splice-variant isoforms (Δ27aa, Δ83aa, Δ103aa, Δ130aa and Δ221aa) were cloned from a TRAF-3+ lymphoma and the expression and function of each of the eight TRAF-3 splice-deletion variants was analyzed. Among the splice-deletion variants, TRAF-3 Δ130 mRNA is expressed by tonsillar B cells and by each of a panel of B and T cell lines. TRAF-3 Δ221 protein is expressed by tonsillar B cells and by each of the lymphocytic lines. The functional effect of over-expressing each TRAF-3 splice-deletion variant on NF-κB activation was studied in 293 T cells. Seven of the TRAF-3 splice-deletion variants, such as TRAF-3 Δ130, induce substantial NF-κB-driven luciferase activity (80-500 fold). In contrast, TRAF-3 Δ221 (in which the complete Zn finger domain is absent) fails to induce NF-κB activation. Although full-length TRAF-3 alone is inactive, it augments the functional effects of the seven activating TRAF-3 splice- deletion variants (1.45 fold). These data indicate that alterations of the Zn finger domains render the TRAF-3 splice-deletion variants capable of inducing NF-κB activation and that full-length TRAF-3 augments their signaling.

AB - Although TRAF-3 gene products are required for signaling in T-B cell collaboration, full-length TRAF-3 appears to lack signaling function in transient transfection assays that measure NF-κB activation. However, the TRAF-3 gene also encodes at least three mRNA splice-deletion variants that predict protein isoforms (Δ25aa, Δ52aa and Δ56aa) with altered zinc (Zn) finger domains and unknown functional capacities. To determine whether TRAF-3 splice-deletion variants may transmit activating receptor signals to the nucleus, cDNAs for five additional splice-variant isoforms (Δ27aa, Δ83aa, Δ103aa, Δ130aa and Δ221aa) were cloned from a TRAF-3+ lymphoma and the expression and function of each of the eight TRAF-3 splice-deletion variants was analyzed. Among the splice-deletion variants, TRAF-3 Δ130 mRNA is expressed by tonsillar B cells and by each of a panel of B and T cell lines. TRAF-3 Δ221 protein is expressed by tonsillar B cells and by each of the lymphocytic lines. The functional effect of over-expressing each TRAF-3 splice-deletion variant on NF-κB activation was studied in 293 T cells. Seven of the TRAF-3 splice-deletion variants, such as TRAF-3 Δ130, induce substantial NF-κB-driven luciferase activity (80-500 fold). In contrast, TRAF-3 Δ221 (in which the complete Zn finger domain is absent) fails to induce NF-κB activation. Although full-length TRAF-3 alone is inactive, it augments the functional effects of the seven activating TRAF-3 splice- deletion variants (1.45 fold). These data indicate that alterations of the Zn finger domains render the TRAF-3 splice-deletion variants capable of inducing NF-κB activation and that full-length TRAF-3 augments their signaling.

KW - Molecular biology

KW - Signal transduction

KW - T cell-B cell collaboration

UR - http://www.scopus.com/inward/record.url?scp=0032823472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032823472&partnerID=8YFLogxK

U2 - 10.1016/S0161-5890(99)00079-6

DO - 10.1016/S0161-5890(99)00079-6

M3 - Article

C2 - 10509816

AN - SCOPUS:0032823472

VL - 36

SP - 647

EP - 658

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 10

ER -